Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1920 1
1932 1
1934 1
1937 1
1946 3
1947 4
1948 4
1951 3
1952 2
1953 4
1955 1
1956 2
1957 1
1958 2
1959 5
1960 3
1961 5
1962 3
1963 3
1964 10
1965 5
1966 3
1967 3
1968 6
1969 4
1970 3
1971 2
1972 2
1973 5
1974 1
1975 7
1976 1
1977 6
1978 5
1979 10
1980 9
1981 15
1982 16
1983 9
1984 19
1985 13
1986 7
1987 13
1988 8
1989 6
1990 12
1991 11
1992 7
1993 12
1994 9
1995 17
1996 15
1997 15
1998 12
1999 26
2000 27
2001 12
2002 15
2003 21
2004 24
2005 19
2006 22
2007 18
2008 24
2009 23
2010 30
2011 22
2012 33
2013 28
2014 51
2015 57
2016 66
2017 45
2018 60
2019 65
2020 72
2021 67
2022 69
2023 30

Text availability

Article attribute

Article type

Publication date

Search Results

1,170 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages.
Obradovic A, Chowdhury N, Haake SM, Ager C, Wang V, Vlahos L, Guo XV, Aggen DH, Rathmell WK, Jonasch E, Johnson JE, Roth M, Beckermann KE, Rini BI, McKiernan J, Califano A, Drake CG. Obradovic A, et al. Among authors: drake cg. Cell. 2021 May 27;184(11):2988-3005.e16. doi: 10.1016/j.cell.2021.04.038. Epub 2021 May 20. Cell. 2021. PMID: 34019793 Free PMC article.
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M. Topalian SL, et al. Among authors: drake cg. N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2. N Engl J Med. 2012. PMID: 22658127 Free PMC article. Clinical Trial.
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer.
Obradovic A, Graves D, Korrer M, Wang Y, Roy S, Naveed A, Xu Y, Luginbuhl A, Curry J, Gibson M, Idrees K, Hurley P, Jiang P, Liu XS, Uppaluri R, Drake CG, Califano A, Kim YJ. Obradovic A, et al. Among authors: drake cg. Clin Cancer Res. 2022 May 13;28(10):2094-2109. doi: 10.1158/1078-0432.CCR-21-3570. Clin Cancer Res. 2022. PMID: 35262677 Free PMC article.
Insomnia disorder.
Morin CM, Drake CL, Harvey AG, Krystal AD, Manber R, Riemann D, Spiegelhalder K. Morin CM, et al. Among authors: drake cl. Nat Rev Dis Primers. 2015 Sep 3;1:15026. doi: 10.1038/nrdp.2015.26. Nat Rev Dis Primers. 2015. PMID: 27189779 Review.
Prostate cancer.
Attard G, Parker C, Eeles RA, Schröder F, Tomlins SA, Tannock I, Drake CG, de Bono JS. Attard G, et al. Among authors: drake cg. Lancet. 2016 Jan 2;387(10013):70-82. doi: 10.1016/S0140-6736(14)61947-4. Epub 2015 Jun 11. Lancet. 2016. PMID: 26074382 Review.
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM. Brahmer JR, et al. Among authors: drake cg. N Engl J Med. 2012 Jun 28;366(26):2455-65. doi: 10.1056/NEJMoa1200694. Epub 2012 Jun 2. N Engl J Med. 2012. PMID: 22658128 Free PMC article. Clinical Trial.
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ, Norton C, Bossé D, Wankowicz SM, Cullen D, Horak C, Wind-Rotolo M, Tracy A, Giannakis M, Hodi FS, Drake CG, Ball MW, Allaf ME, Snyder A, Hellmann MD, Ho T, Motzer RJ, Signoretti S, Kaelin WG Jr, Choueiri TK, Van Allen EM. Miao D, et al. Among authors: drake cg. Science. 2018 Feb 16;359(6377):801-806. doi: 10.1126/science.aan5951. Epub 2018 Jan 4. Science. 2018. PMID: 29301960 Free PMC article.
LAG3 (CD223) as a cancer immunotherapy target.
Andrews LP, Marciscano AE, Drake CG, Vignali DA. Andrews LP, et al. Among authors: drake cg. Immunol Rev. 2017 Mar;276(1):80-96. doi: 10.1111/imr.12519. Immunol Rev. 2017. PMID: 28258692 Free PMC article. Review.
Prostate carcinogenesis: inflammatory storms.
de Bono JS, Guo C, Gurel B, De Marzo AM, Sfanos KS, Mani RS, Gil J, Drake CG, Alimonti A. de Bono JS, et al. Among authors: drake cg. Nat Rev Cancer. 2020 Aug;20(8):455-469. doi: 10.1038/s41568-020-0267-9. Epub 2020 Jun 16. Nat Rev Cancer. 2020. PMID: 32546840 Review.
1,170 results